This Study Consists of Two Study Parts Conducted Under a Single IRB. Part I: Short Term ApoE-dependent Cerebral Blood Flow Response to Sirolimus in Cognitively Normal Adults Part II: Short Term ApoE-dependent Cerebral Blood Flow and Lung Perfusion Response to Sirolimus in Cognitively Normal Adults

Clinical trial NCT05386914 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05386914
Sponsor: University of Missouri-Columbia
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Genetic Predisposition to Disease Healthy Volunteers

Start date: 2023-03-02
Primary completion: 2025-09-19
Enrollment: 205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.